SANJIVANI PARANTERAL
Back to All Ratios
|
SANJIVANI PARANTERAL Last 5 Year Net Sales Growth History
[Consolidated]
| Mar2025 | Mar2024 | |
|---|---|---|
| Net Sales Growth(%) | 28.83 | - |
What is the latest Net Sales Growth ratio of SANJIVANI PARANTERAL ?
| Year | Net Sales Growth |
|---|---|
| Mar2025 | 28.83 |
| Mar2024 | - |
How is Net Sales Growth of SANJIVANI PARANTERAL Trending?
| Years | Net Sales Growth | % Change | |
|---|---|---|---|
| Mar2025 | 28.83 | 0 | |
| Mar2024 | 0 | - | |
Other Financial Ratios of SANJIVANI PARANTERAL
| Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Net Sales Growth ratio of peers of SANJIVANI PARANTERAL
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SANJIVANI PARANTERAL | ₹180.9 Cr | -0.3% | -9.9% | -31.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹430,909.0 Cr | -2.5% | 1% | 7.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹173,930.0 Cr | -3.1% | 0.3% | -1.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹147,181.0 Cr | -4.9% | 2.8% | 37.8% | Stock Analytics | |
| CIPLA | ₹112,353.0 Cr | -1.6% | 5.6% | -5.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,608.0 Cr | -3.2% | -3.1% | 4.8% | Stock Analytics | |
SANJIVANI PARANTERAL Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SANJIVANI PARANTERAL | -0.3% |
-9.9% |
-31.5% |
| SENSEX | -1.5% |
-3.4% |
-9.1% |
You may also like the below Video Courses